Clinical trial
Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing…
NCT00458549 · Dana-Farber Cancer Institute, Other · Terminated
Key facts
| NCT number | NCT00458549 |
|---|---|
| Title | Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or Surgery |
| Official title | Prostate Cancer Prevention by n-3 Unsaturated Fatty Acids |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Dietary Supplement, Procedure |
| Interventions | omega-3 fatty acids, biopsy |
| Enrollment | 232 |
| Start date | May 27, 2003 |
| Primary completion | May 14, 2009 |
| Completion | May 1, 2012 |
| First posted | Apr 11, 2007 |
| Last update posted | Jul 13, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: